Cortical Dysplasia, Genetic Abnormalities and Neurocutaneous Syndromes
Authors:
- Harry V. VintersHVHarry V. Vinters
- Sung Hye ParkSPSung Hye Park
- Michael W. JohnsonMJMichael W. Johnson
- Paul S. MischelPMPaul S. Mischel
- Michael CataniaMCMichael Catania
- Christopher KerfootCKChristopher Kerfoot
- 1 November 1999
- journal article
- review article
- Published by S. Karger AG in Developmental Neuroscience
- Vol. 21 (3-5) , 248-259
Abstract
Cortical dysplasia (CD) represents a common neuropathologic substrate of pediatric epilepsy, one frequently encountered in surgical resection specimens from infants and children with intractable seizure disorders, including infantile spasms. Severe CD shows similarities to structural features noted in tubers from individuals with tuberous sclerosis (TSC). The latter disorder, one with neurocutaneous and visceral manifestations, results from mutations in one of two recently cloned genes, TSC1 or TSC2, which encode (respectively) the proteins hamartin and tuberin. There is circumstantial evidence that both proteins may influence cell growth and differentiation, specifically that they may represent growth suppressors. Neither protein has a defined role in brain development. We discuss and illustrate neuropathologic features of both CD and TSC, and discuss the patterns and time course of hamartin/tuberin expression in normal brain, CD and TSC. Other recently cloned genes associated with cortical malformations encompassed by the term CD are briefly described.Keywords
This publication has 17 references indexed in Scilit:
- Cortical Dysplasia, Genetic Abnormalities and Neurocutaneous SyndromesDevelopmental Neuroscience, 1999
- Cellular and molecular basis of cerebral dysgenesisJournal of Neuroscience Research, 1997
- Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34Science, 1997
- The Tuberous Sclerosis 2 Gene Product, Tuberin, Functions as a Rab5 GTPase Activating Protein (GAP) in Modulating EndocytosisJournal of Biological Chemistry, 1997
- Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regionsActa Neuropathologica, 1997
- Embryonic neuronal markers in tuberous sclerosis: Single-cell molecular pathologyProceedings of the National Academy of Sciences, 1996
- Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITYJournal of Biological Chemistry, 1995
- Parvalbumin and calbindin-D28k immunocytochemistry in human neocortical epileptic fociJournal of the Neurological Sciences, 1994
- Recipe for a good research laboratoryNature, 1993
- Development and decision-making in the mammalian cerebral cortexBrain Research Reviews, 1988